HWS116

· Wuhan Humanwell Innovative Drug Research and Development Center Limited Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HWS116, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: HWS116 Monotherapy in Patients With Advanced Solid Tumors [Phase 1]